Nicklaus Childrens Hospital
Miami, Florida 33199
61 studies enrolling now · 238 studies all time
What they study most
ADH Inappropriate, Abdominal Pain, Acute Graft-versus-host Disease, Acute Leukemia of Ambiguous Lineage, Acute Lung Injury, Acute Lymphoblastic Leukemia, Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA, Acute Undifferentiated Leukemia, Adamantinomatous Craniopharyngioma
Studies at this site
- A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab — Recruiting now
- A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome — Recruiting now
- A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) — Recruiting now
- A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma — Recruiting now
- A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma — Recruiting now
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma — Recruiting now
- A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis — Recruiting now
- A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome — Recruiting now
- REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome — Recruiting now
- A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations — Recruiting now
- A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo — Recruiting now
- Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT — Recruiting now
- Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder — Recruiting now
- Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer — Recruiting now
- Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors — Recruiting now
- A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma — Recruiting now
- Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy — Recruiting now
- A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss — Recruiting now
- Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up — Recruiting now
- Diagnosing Epilepsy To EffeCT Change — Recruiting now
- Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. — Recruiting now
- Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN — Recruiting now
- Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body — Recruiting now
- Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors — Recruiting now
- Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas — Recruiting now
- Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma — Recruiting now
- Rett Syndrome Registry — Recruiting now
- A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects — Recruiting now
- TSC Biosample Repository and Natural History Database — Recruiting now
- A Study to Assess Growth in Children With Idiopathic Short Stature — Recruiting now
- The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study — Recruiting now
- A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature — Recruiting now
- A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease — Recruiting now
- ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas — Recruiting now
- Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases — Recruiting now
- PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma — Recruiting now
- A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment — Recruiting now
- A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients — Recruiting now
- A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) — Recruiting now
- Project: Every Child for Younger Patients With Cancer — Recruiting now
- Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma — Recruiting now
- A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT — Recruiting now
- A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT — Recruiting now
- Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma — Recruiting now
- Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma — Recruiting now
- DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma — Recruiting now
- Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma — Recruiting now
- ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma — Recruiting now
- A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM). — Recruiting now
- MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma — Recruiting now